Dr. Kennedy Chima Ukadike, MD

Dr. Ukadike practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Dr. Ukadike's NPI, 1346637295, was assigned on April 17, 2015. Dr. Ukadike graduated from Ross University School of Medicine in 2013. Dr. Ukadike's Nevada license number on file is 21622.

Dr. Ukadike's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Dr. Ukadike's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Dr. Ukadike is also affiliated with Renown South Meadows Medical Center. The medical group on file is Renown Health. Dmand AI also links Dr. Ukadike to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ukadike practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Ukadike's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Ukadike is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ukadike's licenses on file in 3 states: Nevada, Washington and New Jersey.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus and rheumatoid arthritis among the conditions Dr. Ukadike treats.

CMS data shows 390 Medicare services from Dr. Ukadike across 4 procedure codes in 2024, for 212 Medicare patients. Medicare paid $25,310 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Dr. Ukadike in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have arthritis, and 70% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ukadike's median patient age at 71, with 69% women.

In 2024, Dr. Ukadike wrote 964 Medicare Part D claims for 177 patients. 70% of them were for generic drugs. CMS names the drug for 838 of them, across 22 drugs with 11 or more claims each, at $1,258,685 in total drug cost. In 2023, CMS named 829 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Ukadike for performance year 2024, reported as part of a group. Dr. Ukadike accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ukadike as offering telehealth.

Dmand AI links 8 papers to Dr. Ukadike, published from 2019 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Autoantibodies, Long Interspersed Nucleotide Elements and Lupus Erythematosus, Systemic. Dr. Ukadike's most frequent co-authors are Rayan J. Najjar, MD, MPH and Alison Marie Bays, MD.

CMS Open Payments shows 20 general payments to Dr. Ukadike from 9 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 85% of the total. GlaxoSmithKline, LLC. paid the most, $263.

Dr. Ukadike graduated from Ross University School of Medicine in 2013. Dr. Ukadike is a member of ACP, ACR and FOCIS.

Dr. Ukadike is in network with 9 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.